⌘K

Login Start Free

Home/Filings/4/0001079973-10-000752

4//SEC Filing

PURE BIOSCIENCE 4

Accession 0001079973-10-000752

$PURECIK 0001006028operating

View on SEC.gov Company Profile

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 7:44 PM ET

Size

14.7 KB

Accession

0001079973-10-000752

Insider Transaction Report

Form 4

Period: 2010-07-07

PURE BIOSCIENCEPURE

DirectorVP and Asst Secretary

Transactions

Exercise/Conversion
Common Stock
2010-07-07$0.53/sh+21,108$11,187→ 372,755 total
Sale
Common Stock
2010-07-07$2.03/sh−21,108$42,927→ 372,755 total
Exercise/Conversion
Stock Option
2010-07-07−21,108→ 20,000 total
Exercise: $0.53From: 2001-01-08Exp: 2011-01-07→ Common Stock (21,108 underlying)
Exercise/Conversion
Common Stock
2010-07-08$0.53/sh+8,892$4,713→ 372,755 total
Exercise/Conversion
Stock Option
2010-07-08−8,892→ 20,000 total
Exercise: $0.53From: 2001-01-08Exp: 2011-01-07→ Common Stock (8,892 underlying)
Sale
Common Stock
2010-07-08$2.48/sh−8,892$22,052→ 372,755 total

Footnotes (3)

[F1]Transactions pursuant to Rule 10B5-1 Plan
[F2]Incorporates all transactions reported on this Form 4
[F3]Granted pursuant to 2001 Directors and Officers Stock Option Plan

Documents

1 file

4
pure_singer4.xmlPrimary

Issuer

PURE BIOSCIENCE

CIK 0001006028

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001006028

Filing Metadata

Form type: 4
Filed: Jul 8, 8:00 PM ET
Accepted: Jul 9, 7:44 PM ET
Size: 14.7 KB

View on SEC.gov